27598153|t|Nicotine Suppressed Fetal Adrenal StAR Expression via YY1 Mediated- Histone Deacetylation Modification Mechanism
27598153|a|Steroidogenic acute regulatory (StAR) protein plays a pivotal role in steroidogenesis. Previously, we have demonstrated that prenatal nicotine exposure suppressed fetal adrenal steroidogenesis via steroidogenic factor 1 deacetylation. This study further explored the potential role of the transcriptional repressor Yin Yang 1 (YY1) in nicotine -mediated StAR inhibition. Nicotine was subcutaneously administered (1.0 mg/kg) to pregnant rats twice per day and NCI-H295A cells were treated with nicotine. StAR and YY1 expression were analyzed by real-time PCR, immunohistochemistry, and Western blotting. Histone modifications and the interactions between the YY1 and StAR promoter were assessed using chromatin immunoprecipitation (ChIP). Prenatal nicotine exposure increased YY1 expression and suppressed StAR expression. ChIP assay showed that there was a decreasing trend for histone acetylation at the StAR promoter in fetal adrenal glands, whereas H3 acetyl-K14 at the YY1 promoter presented an increasing trend following nicotine exposure. Furthermore, in nicotine - treated NCI-H295A cells, nicotine enhanced YY1 expression and inhibited StAR expression. ChIP assay showed that histone acetylation decreased at the StAR promoter in NCI-H295A cells and that the interaction between the YY1 and StAR promoter increased. These data indicated that YY1 -medicated histone deacetylation modification in StAR promoters might play an important role in the inhibitory effect of nicotine on StAR expression.
27598153	0	8	Nicotine	T109,T131	C0028040
27598153	9	19	Suppressed	T169	C1260953
27598153	20	33	Fetal Adrenal	T023	C0229565
27598153	34	38	StAR	T116	C0290758
27598153	39	49	Expression	T045	C1171362
27598153	54	57	YY1	T116,T123	C0903890
27598153	68	89	Histone Deacetylation	T044	C1156201
27598153	90	102	Modification	T169	C0392747
27598153	103	112	Mechanism	T169	C0441712
27598153	113	158	Steroidogenic acute regulatory (StAR) protein	T116	C0290758
27598153	183	198	steroidogenesis	T044	C0597513
27598153	238	246	prenatal	T079	C2828394
27598153	247	255	nicotine	T109,T131	C0028040
27598153	256	264	exposure	T080	C0332157
27598153	265	275	suppressed	T169	C1260953
27598153	276	289	fetal adrenal	T023	C0229565
27598153	290	305	steroidogenesis	T044	C0597513
27598153	310	332	steroidogenic factor 1	T116,T123	C0171961
27598153	333	346	deacetylation	T044	C1511737
27598153	402	427	transcriptional repressor	T116,T123	C1336789
27598153	428	438	Yin Yang 1	T116,T123	C0903890
27598153	440	443	YY1	T116,T123	C0903890
27598153	448	456	nicotine	T109,T131	C0028040
27598153	467	471	StAR	T116	C0290758
27598153	472	482	inhibition	T052	C3463820
27598153	484	492	Nicotine	T109,T131	C0028040
27598153	497	524	subcutaneously administered	T033	C1736929
27598153	540	548	pregnant	T040	C0032961
27598153	549	553	rats	T015	C0034721
27598153	572	587	NCI-H295A cells	T025	C0007634
27598153	593	600	treated	T169	C1522326
27598153	606	614	nicotine	T109,T131	C0028040
27598153	616	620	StAR	T116	C0290758
27598153	625	628	YY1	T116,T123	C0903890
27598153	629	639	expression	T045	C1171362
27598153	657	670	real-time PCR	T063	C1709846
27598153	672	692	immunohistochemistry	T060	C0021044
27598153	698	714	Western blotting	T059,T063	C0005863
27598153	716	737	Histone modifications	T044	C1156199
27598153	746	758	interactions	T169	C1704675
27598153	771	774	YY1	T116,T123	C0903890
27598153	779	792	StAR promoter	T028	C1420453
27598153	798	806	assessed	T052	C1516048
27598153	813	842	chromatin immunoprecipitation	T059	C1328856
27598153	844	848	ChIP	T059	C1328856
27598153	851	859	Prenatal	T079	C2828394
27598153	860	868	nicotine	T109,T131	C0028040
27598153	869	877	exposure	T080	C0332157
27598153	878	887	increased	T169	C0442808
27598153	888	891	YY1	T116,T123	C0903890
27598153	892	902	expression	T045	C1171362
27598153	907	917	suppressed	T169	C1260953
27598153	918	922	StAR	T116	C0290758
27598153	923	933	expression	T045	C1171362
27598153	935	939	ChIP	T059	C1328856
27598153	940	945	assay	T059	C1510438
27598153	970	980	decreasing	T033	C0442797
27598153	991	1010	histone acetylation	T044	C1156200
27598153	1018	1031	StAR promoter	T028	C1420453
27598153	1035	1055	fetal adrenal glands	T023	C0229565
27598153	1065	1078	H3 acetyl-K14	T044	C2752447
27598153	1086	1098	YY1 promoter	T028	C1421565
27598153	1112	1122	increasing	T169	C0442808
27598153	1139	1147	nicotine	T109,T131	C0028040
27598153	1148	1156	exposure	T080	C0332157
27598153	1174	1182	nicotine	T109,T131	C0028040
27598153	1185	1192	treated	T169	C1522326
27598153	1193	1208	NCI-H295A cells	T025	C0007634
27598153	1210	1218	nicotine	T109,T131	C0028040
27598153	1228	1231	YY1	T116,T123	C0903890
27598153	1232	1242	expression	T045	C1171362
27598153	1247	1256	inhibited	T052	C3463820
27598153	1257	1261	StAR	T116	C0290758
27598153	1262	1272	expression	T045	C1171362
27598153	1274	1278	ChIP	T059	C1328856
27598153	1279	1284	assay	T059	C1510438
27598153	1297	1316	histone acetylation	T044	C1156200
27598153	1317	1326	decreased	T033	C0442797
27598153	1334	1347	StAR promoter	T028	C1420453
27598153	1351	1366	NCI-H295A cells	T025	C0007634
27598153	1380	1391	interaction	T169	C1704675
27598153	1404	1407	YY1	T116,T123	C0903890
27598153	1412	1425	StAR promoter	T028	C1420453
27598153	1426	1435	increased	T169	C0442808
27598153	1463	1466	YY1	T116,T123	C0903890
27598153	1478	1499	histone deacetylation	T044	C1156201
27598153	1500	1512	modification	T169	C0392747
27598153	1516	1530	StAR promoters	T028	C1420453
27598153	1567	1584	inhibitory effect	T052	C3463820
27598153	1588	1596	nicotine	T109,T131	C0028040
27598153	1600	1604	StAR	T028	C1420453
27598153	1605	1615	expression	T045	C0017262